Skip to content

Clinical trials

Phase 3 Lymphoma, B-Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 3 Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20131
20191
20201
20214
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Completed4
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Novartis Pharmaceuticals2
Acerta Pharma BV1
BeOne Medicines1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Millennium Pharmaceuticals, Inc.1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell13
Lymphoma, Non-Hodgkin9
Hematologic Diseases5
Lymphoma5
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Mantle-Cell2
Hematologic Neoplasms1
Leukemia, B-Cell1
Leukemia, Lymphoid1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.